{
    "patient_id": "patient_056",
    "name": "George Anderson",
    "demographics": {
        "age": 74,
        "sex": "M",
        "date_of_birth": "1951-12-05"
    },
    "medical_history": {
        "conditions": ["Primary open-angle glaucoma", "Overactive bladder", "Benign prostatic hyperplasia"],
        "medications": ["Latanoprost 0.005% eye drops QHS", "Tamsulosin 0.4mg daily"],
        "allergies": ["None"]
    },
    "current_visit": {
        "date": "2026-01-28",
        "provider": "Dr. Patricia Murphy",
        "diagnosis": "Overactive bladder - worsening symptoms",
        "procedures": ["Office visit", "Urinalysis"],
        "prescriptions": ["Continue home medications", "Oxybutynin 5mg TID (NEW)"]
    },
    "expected_issues": [{
        "issue_type": "drug_disease_contraindication",
        "severity": "critical",
        "description": "Anticholinergic agent (Oxybutynin) in patient with glaucoma - acute angle-closure risk",
        "fields_involved": ["medications", "prescriptions", "conditions"],
        "reasoning": "Anticholinergic medications cause pupillary dilation (mydriasis), which can precipitate acute angle-closure glaucoma attack - sudden IOP elevation causing severe eye pain, vision loss, and potential permanent blindness. While patient has open-angle glaucoma (not angle-closure), anticholinergics can still worsen IOP control. Alternative treatments (beta-3 agonists like mirabegron) should be used.",
        "domain_knowledge_required": true
    }]
}